CA
GOSS icon

Cetera Advisors’s Gossamer Bio GOSS Stock Holding History

Cetera Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$11.8K Buy
+10,036
New +$11K ﹤0.01% 2408

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Cetera Advisors's GOSS Position: Q1 2024 in Review

Cetera Advisors opened a new position in Gossamer Bio (GOSS) in Q1 2024: 10,036 shares worth $11.8K. The stake represents ﹤0.01% of the portfolio and ranks #2408 among its holdings.

110 funds tracked by Wall St. Rank hold GOSS as of Q1 2024.

  • Cetera Advisors held 10,036 shares of Gossamer Bio worth $11.8K as of Q1 2024.
  • Gossamer Bio was a new Cetera Advisors position in Q1 2024.
  • Gossamer Bio made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2408 holding.
  • 110 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.